Nipah Virus Infection

Authors

  • Mounika Puppala Scientific Analyst, Molecular Connections Private Limited, Bangalore, Karnataka, India.
  • Keerthi Yelavarthi Scientific Analyst, Molecular Connections Private Limited, Bangalore, Karnataka, India.

DOI:

https://doi.org/10.61427/jcpr.v1.i1.2021.11

Keywords:

Ephrin-B2, Nipah virus, Ribavarin

Abstract

Nipah virus is a type of RNA virus and this virus may usually circulate among specific types of fruit bats. In the year 1998, this disease was first identified by a team of scientists at the Faculty of Medicine, University of Malaya in Malaysia and the disease was named after a village called Sungai Nipah in Malaysia. The out breaks of Nipah virus infection have been reported in Malaysia, India, Singapore, Bangladesh and Philippines. Typically, the spread requires direct contact with an infected source. Through the oro-nasal route, the virus enters its host and causes the infection. From the terminal stages of the disease, human tissues have only been studied and the site of the initial replication was found to be unknown. After the exposure of the virus, it may take 5-14 days for the onset of the symptoms. The symptoms of Nipah virus infection can be fever, headache, cough, shortness of breath and confusion. This review article was mainly focused in describing various aspects of Nipah virus infection. Human to human nosocomial infections can be prevented by strictly following the standard infection control practices. Implementation of infection control practices like isolation of patients, good hand hygiene practices and the use of personal protective equipments may help us in the prevention of person to person transmission. Health care workers exposed to the suspected Nipah virus patients must inform their higher officials and should undergo testing for the Nipah virus. Discourage the funeral practices that require the direct contact with the remains.

Downloads

Download data is not yet available.

References

Chua KB. Nipah virus outbreak in Malaysia. Journal of Clinical Virology. 2003; 26: 265-75.

Aditi, Shariff M. Nipah virus infection: A review. Epidemiology and Infection. 2019; 147: 1-6.

Paton NI et al. Outbreak of Nipah-virus infection among abattoir workers in Singapore. The Lancet. 1999; 354: 1253-6.

Parashar UD et al. Case?control study of risk factors for human infection with a new zoonotic Paramyxovirus, Nipah virus, during a 1998–1999 outbreak of severe encephalitis in Malaysia. The Journal of Infectious Diseases. 2000; 181: 1755-9.

WHO - Nipah Virus Infection. Available at http://www.who.int/csr/disease/nipah/en/.

Wong KT et al. Nipah virus infection: Pathology and pathogenesis of an emerging paramyxoviral zoonosis. The American Journal of Pathology. 2002; 161: 2153-67.

Liebl DJ et al. mRNA expression of ephrins and Eph receptor tyrosine kinases in the neonatal and adult mouse central nervous system. Journal of Neuroscience Research. 2003; 71: 7-22.

Zimmer M et al. Ephb–ephrinB bi-directional endocytosis terminates adhesion allowing contact-mediated repulsion. Nature Cell Biology. 2003; 5: 869-78.

Bossart KN et al. Functional studies of host-specific ephrin-B ligands as Henipavirus receptors. Virology 2008; 372: 357-71.

Siva S, Chong H, Tan C. Ten year clinical and serological outcomes of Nipah virus infection. Neurology Asia. 2009; 14: 53-8.

Abdullah S, Tan CT. Henipavirus encephalitis. Handbook of Clinical Neurology 2014; 123: 663-70.

Banerjee S et al. Nipah virus disease: A rare and intractable disease. Intractable & Rare Diseases Research. 2019; 8(1): 1-8.

Sharma, V et al. Emerging trends of Nipah virus: A review. Reviews in Medical Virology. 2019; 29 (1): e2010.

Lo, Michael K et al. "Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge". Science Translational Medicine. 2019; 11(494): eaau9242.

Published

2021-01-14
Statistics
235 Views | 205 Downloads
Citatons

How to Cite

Puppala, M. ., and K. . Yelavarthi. “Nipah Virus Infection”. Journal of Clinical and Pharmaceutical Research, vol. 1, no. 1, Jan. 2021, pp. 13-15, doi:10.61427/jcpr.v1.i1.2021.11.

Issue

Section

Review Articles